{"transactions":[{"id":2471386,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-15T21:22:17.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022."}],"balance_after":275000,"derivative":{"exercise_price":0.92,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000905718-21-001609","document":"matinas_fm4dec152021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571821001609/matinas_fm4dec152021.xml","form_type":"4"}},{"id":2570537,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-09-14T17:30:10.000Z","date":"2021-09-03","kind":"other","acquired":true,"shares":462150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received pursuant to an amendment to the Agreement and Plan of Merger dated as of January 29, 2015 by an among the Issuer, Saffron Merger Sub, Inc. and Aquarius Biotechnologies Inc."}],"balance_after":1919715,"source":{"system":"sec-edgar","filing":"0001493152-21-022716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315221022716/ownership.xml","form_type":"4"}},{"id":2655697,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series B Preferred Stock","published_at":"2021-06-24T17:35:04.000Z","date":"2021-06-19","kind":"exercise","acquired":false,"shares":10,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000905718-21-000822","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571821000822/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655696,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:35:04.000Z","date":"2021-06-19","kind":"exercise","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 19, 2021, pursuant to the Certificate of Designations of Preferences, Rights and Limitations of the Series B Preferred Stock (the \"Certificate\") of the Issuer, all shares of Series B Convertible Preferred Stock were mandatorily converted into shares of the Issuer's common stock. Each share of Series B Convertible Preferred Stock converted into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock were convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate. The Series B Convertible Preferred Stock had no expiration date."}],"balance_after":1457565,"source":{"system":"sec-edgar","filing":"0000905718-21-000822","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571821000822/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2655695,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-06-24T17:35:04.000Z","date":"2021-06-19","kind":"other","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 400 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":1437565,"source":{"system":"sec-edgar","filing":"0000905718-21-000822","document":"matinasbio_fm4jun192021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571821000822/matinasbio_fm4jun192021.xml","form_type":"4"}},{"id":2925242,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-04T18:30:13.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022."}],"balance_after":200000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-000135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315221000135/ownership.xml","form_type":"4"}},{"id":3100715,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-06-24T21:00:17.000Z","date":"2020-06-23","kind":"other","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of record of Series B Preferred Stock of 300 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":1429565,"source":{"system":"sec-edgar","filing":"0001493152-20-011760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315220011760/ownership.xml","form_type":"4"}},{"id":3104101,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-06-19T17:30:17.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the \"Milestone\"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone."}],"balance_after":50000,"derivative":{"exercise_price":0.815,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-20-011534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315220011534/ownership.xml","form_type":"4"}},{"id":3322159,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T16:06:02.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021."}],"balance_after":100000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-000125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315220000125/ownership.xml","form_type":"4"}},{"id":3322158,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-01-03T16:06:02.000Z","date":"2019-06-21","kind":"other","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock dividend, payable to all holders of records of Series B Preferred Stock of 200 shares of Common Stock for each share of Series B Preferred Stock."}],"balance_after":1426565,"source":{"system":"sec-edgar","filing":"0001493152-20-000125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000149315220000125/ownership.xml","form_type":"4"}},{"id":3659976,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-02-13T18:35:44.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% of the shares on February 11, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on March 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":150000,"derivative":{"exercise_price":1.08,"expiration_date":"2029-02-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000905718-19-000108","document":"mannino-matinasfm4_feb112019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571819000108/mannino-matinasfm4_feb112019.xml","form_type":"4"}},{"id":3884784,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-06-22T16:40:21.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":10,"price":1000,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 10 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On June 21, 2018, the Reporting Person purchased 10 shares of Series B Convertible Preferred Stock from the Issuer in a public offering. Each share of Series B Convertible Preferred Stock is convertible into 2,000 shares of the Issuer's common stock. The shares of Series B Convertible Preferred Stock are convertible at any time, at the holder's election, or upon certain mandatory conversion events set forth in the Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock of the Issuer. The Series B Convertible Preferred Stock has no expiration date."}],"balance_after":10,"derivative":{"exercise_price":0.5,"exercise_date":"2018-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000905718-18-000590","document":"mannino-matinasfm4_jun212018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571818000590/mannino-matinasfm4_jun212018.xml","form_type":"4"}},{"id":3949577,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-02T17:15:10.000Z","date":"2018-04-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on April 30, 2019 and the remaining shares vest in equal monthly installments over the next 36 months."}],"balance_after":150000,"derivative":{"exercise_price":0.44,"expiration_date":"2028-04-29","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0000905718-18-000452","document":"matinasbiopfm4_apr302018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571818000452/matinasbiopfm4_apr302018.xml","form_type":"4"}},{"id":4208188,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":132350,"kind":"person","name":"MANNINO RAPHAEL J","position":1,"cik":"0001196697","reported_name":"MANNINO RAPHAEL J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-09-15T16:18:11.000Z","date":"2017-09-11","kind":"purchase","acquired":true,"shares":5000,"price":1.41,"value":7050.0,"ownership":{"direct":true},"balance_after":1424565,"source":{"system":"sec-edgar","filing":"0000905718-17-000833","document":"mannino_fm4sept112017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1196697/000090571817000833/mannino_fm4sept112017.xml","form_type":"4"}}]}